Zhang L - Search Results

1

Therapeutic protein-drug interactions and implications for drug development.

Huang SM, Zhao H, Lee JI, Reynolds K, Zhang L, Temple R, Lesko LJ. Huang SM, et al. Among authors: zhang l. Clin Pharmacol Ther. 2010 Apr;87(4):497-503. doi: 10.1038/clpt.2009.308. Epub 2010 Mar 3. Clin Pharmacol Ther. 2010. PMID: 20200513

2

The molecular epidemiology of transfusion transmitted virus infection in Shanxi Province.

Zhao H, Zhang L, Yang H. Zhao H, et al. Among authors: zhang l. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000 Jun;14(2):166-8. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000. PMID: 11503053

3

[Effects of homocysteine on human vascular endothelial cells, platelet aggregation and heparin cofactor activity].

Zhang G, Zhao H, Zhang L. Zhang G, et al. Among authors: zhang l. Zhonghua Xue Ye Xue Za Zhi. 1999 Sep;20(9):471-3. Zhonghua Xue Ye Xue Za Zhi. 1999. PMID: 11721411 Chinese.

4

Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications.

Zhang Y, Zhang L, Abraham S, Apparaju S, Wu TC, Strong JM, Xiao S, Atkinson AJ Jr, Thummel KE, Leeder JS, Lee C, Burckart GJ, Lesko LJ, Huang SM. Zhang Y, et al. Among authors: zhang l. Clin Pharmacol Ther. 2009 Mar;85(3):305-11. doi: 10.1038/clpt.2008.208. Epub 2008 Nov 19. Clin Pharmacol Ther. 2009. PMID: 19020495

5

When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective.

Huang SM, Temple R, Xiao S, Zhang L, Lesko LJ. Huang SM, et al. Among authors: zhang l. Clin Pharmacol Ther. 2009 Nov;86(5):475-9. doi: 10.1038/clpt.2009.190. Clin Pharmacol Ther. 2009. PMID: 19844224

6

The International Transporter Consortium: a collaborative group of scientists from academia, industry, and the FDA.

Huang SM, Zhang L, Giacomini KM. Huang SM, et al. Among authors: zhang l. Clin Pharmacol Ther. 2010 Jan;87(1):32-6. doi: 10.1038/clpt.2009.236. Clin Pharmacol Ther. 2010. PMID: 20019700

7

Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.

Zhao P, Zhang L, Grillo JA, Liu Q, Bullock JM, Moon YJ, Song P, Brar SS, Madabushi R, Wu TC, Booth BP, Rahman NA, Reynolds KS, Gil Berglund E, Lesko LJ, Huang SM. Zhao P, et al. Among authors: zhang l. Clin Pharmacol Ther. 2011 Feb;89(2):259-67. doi: 10.1038/clpt.2010.298. Epub 2010 Dec 29. Clin Pharmacol Ther. 2011. PMID: 21191381

8

Transporter-mediated drug-drug interactions.

Zhang L, Huang SM, Lesko LJ. Zhang L, et al. Clin Pharmacol Ther. 2011 Apr;89(4):481-4. doi: 10.1038/clpt.2010.359. Clin Pharmacol Ther. 2011. PMID: 21423238

9

Predicting drug interaction potential with a physiologically based pharmacokinetic model: a case study of telithromycin, a time-dependent CYP3A inhibitor.

Vieira ML, Zhao P, Berglund EG, Reynolds KS, Zhang L, Lesko LJ, Huang SM. Vieira ML, et al. Among authors: zhang l. Clin Pharmacol Ther. 2012 Apr;91(4):700-8. doi: 10.1038/clpt.2011.305. Epub 2012 Mar 7. Clin Pharmacol Ther. 2012. PMID: 22398966

10

The UCSF-FDA TransPortal: a public drug transporter database.

Morrissey KM, Wen CC, Johns SJ, Zhang L, Huang SM, Giacomini KM. Morrissey KM, et al. Among authors: zhang l. Clin Pharmacol Ther. 2012 Nov;92(5):545-6. doi: 10.1038/clpt.2012.44. Clin Pharmacol Ther. 2012. PMID: 23085876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134,373 results

Search Page

Filters